05:25:32 EST Sun 17 Nov 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Canvass Ventures Ltd
Symbol CVS
Shares Issued 9,110,000
Close 2019-02-12 C$ 0.10
Recent Sedar Documents

Canvass Ventures receives conditional OK for QT

2019-05-24 19:15 ET - News Release

Mr. Martin Burian reports

CANVASS VENTURES LTD. AND NANALYSIS CORP. ANNOUNCE TSXV CONDITIONAL APPROVAL AND FILING OF FILING STATEMENT

Canvass Ventures Ltd. has received conditional approval from the TSX Venture Exchange for its previously announced qualifying transaction (as defined under TSX-V Policy 2.4) with Nanalysis Corp., whereby Canvass will acquire all of the outstanding Class A common shares of Nanalysis by way of a three-corner amalgamation among Canvass, Nanalysis and 2176406 Alberta Ltd., a wholly owned subsidiary of Canvass. Pursuant to the transaction, Canvass will change its name to Nanalysis Scientific Corp.

Canvass has filed its filing statement dated May 24, 2019, with respect to the transaction. For further details with respect to the transaction, please see the filing statement which is available under Canvass's profile on SEDAR.

Assuming all conditions for closing are satisfied, it is expected that the transaction and the previously announced concurrent non-brokered private placement of Canvass for gross proceeds of up to $5-million at 60 cents per unit will be completed on or around June 4, 2019.

Shortly after closing the transaction, the resulting issuer is expected to commence trading on the TSX-V under the trading symbol NSCI.

We seek Safe Harbor.

© 2019 Canjex Publishing Ltd. All rights reserved.